CMS Announces Final Changes to MA, Part D Payment Policies for 2019

Apr 02, 2018 - 04:29 PM
CMS_update

The Centers for Medicare & Medicaid Services today announced final changes to Medicare Advantage and Part D payment policies for calendar year 2019. CMS anticipates the MA plans and Part D sponsors will see an average revenue increase of 3.4%, excluding an expected 3.1% increase in risk scores. CMS finalized changes to the risk adjustment model for aged and disabled beneficiaries enrolled in MA Part C plans beginning in CY 2019, as required by the 21st Century Cures Act, and additional changes to MA and Part D payment policies for CY 2019. CMS must phase in the new risk adjustment model over four years and will use a 25% to 75% blend of the new and previous risk adjustment model for 2019. In addition, the agency will update the MA risk adjustment models for end-stage renal disease plans in 2019, among other changes. However, CMS will not move forward with the proposed changes to the Part D risk adjustment model. The agency also included several changes to combat opioid overuse. AHA will provide more information on the final changes to members soon.

Related News Articles

Headline
White paper explains use of mock claims for advanced explanation of benefits 
The AHA Jan. 26 released a white paper on addressing challenges in implementing an advanced explanation of benefits, which requires coordination among multiple…
Headline
White House releases health care plan
The White House released a health care plan Jan. 15 addressing drug prices, health insurance premiums and price transparency efforts. The plan includes…
Headline
CMS proposes new drug pricing model to expand GLP-1 access to those with Medicare Part D and Medicaid
The Centers for Medicare & Medicaid Services Dec. 23 introduced a new drug pricing model for Medicare Part D and Medicaid beneficiaries. The Better…
Headline
CMS releases proposed rules on two drug pricing models
The Centers for Medicare & Medicaid Services Dec. 19 issued two proposed rules for implementing alternative drug pricing models. The first proposed…
Headline
AHA comments on proposed ‘public charge’ rule
The AHA Dec. 19 submitted comments on the Department of Homeland Security’s proposed rule regarding the Public Charge Ground of Inadmissibility, urging the…
Headline
Administration reaches deals with 9 drug companies to lower drug costs
The White House announced Dec. 19 that it reached most-favored-nation deals with nine pharmaceutical companies, aligning their drug prices with the lowest paid…